Tandem Diabetes Care (TNDM)
(Delayed Data from NSDQ)
$47.30 USD
+0.37 (0.79%)
Updated May 17, 2024 04:00 PM ET
After-Market: $47.32 +0.02 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TNDM 47.30 +0.37(0.79%)
Will TNDM be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for TNDM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TNDM
Tandem Diabetes (TNDM) Hits 52-Week High: What's Driving It?
Tandem Diabetes (TNDM) Posts Narrower Q1 Loss, Raises '24 View
TNDM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tandem Diabetes Care (TNDM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
Idexx Laboratories (IDXX) Tops Q1 Earnings Estimates
Other News for TNDM
Eminence Capital's Q1 moves include adding MNDY, J, exiting SCHW, FROG
What's Driving Tandem Diabetes Care Inc's Surprising 89% Stock Rally?
Piper Sandler Reaffirms Their Buy Rating on Tandem Diabetes Care (TNDM)
Tandem insulin pump error leads to FDA Class I recall
FDA announces Tandem Diabetes recall of t:connect mobile app